- Home
- IPHA vs EVG Comparison
IPHA vs EVG Comparison
Compare IPHA & EVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- EVG
- Stock Information
- Founded
- IPHA 1999
- EVG 2005
- Country
- IPHA France
- EVG United States
- Employees
- IPHA N/A
- EVG N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- EVG Investment Managers
- Sector
- IPHA Health Care
- EVG Finance
- Exchange
- IPHA Nasdaq
- EVG Nasdaq
- Market Cap
- IPHA 160.1M
- EVG 149.9M
- IPO Year
- IPHA 2019
- EVG N/A
- Fundamental
- Price
- IPHA $1.98
- EVG $10.98
- Analyst Decision
- IPHA Strong Buy
- EVG
- Analyst Count
- IPHA 1
- EVG 0
- Target Price
- IPHA $11.50
- EVG N/A
- AVG Volume (30 Days)
- IPHA 16.2K
- EVG 49.4K
- Earning Date
- IPHA 03-27-2025
- EVG 01-01-0001
- Dividend Yield
- IPHA N/A
- EVG 8.68%
- EPS Growth
- IPHA N/A
- EVG N/A
- EPS
- IPHA N/A
- EVG N/A
- Revenue
- IPHA $20,831,349.00
- EVG N/A
- Revenue This Year
- IPHA $220.44
- EVG N/A
- Revenue Next Year
- IPHA $81.85
- EVG N/A
- P/E Ratio
- IPHA N/A
- EVG N/A
- Revenue Growth
- IPHA N/A
- EVG N/A
- 52 Week Low
- IPHA $1.29
- EVG $9.13
- 52 Week High
- IPHA $3.51
- EVG $10.86
- Technical
- Relative Strength Index (RSI)
- IPHA 48.63
- EVG 46.70
- Support Level
- IPHA $1.77
- EVG $10.91
- Resistance Level
- IPHA $2.03
- EVG $11.24
- Average True Range (ATR)
- IPHA 0.08
- EVG 0.12
- MACD
- IPHA -0.01
- EVG 0.01
- Stochastic Oscillator
- IPHA 65.63
- EVG 43.48
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About EVG Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest
Eaton Vance Short Duration Diversified Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income with a secondary objective of seeking capital appreciation to the extent consistent with its primary goal. The portfolio of investments consists of business equipment and services, automotive, cable and satellite television, chemicals and plastics, food products, and other areas.